For the melanoma patients who signed on to try a drug known as PLX4032, the clinical trial was a last resort. Their bodies were riddled with tumors, leaving them almost certainly just months to live.
But a few weeks after taking their first dose, nearly all of them began to recover.
Seeded on Tue Feb 23, 2010 11:10 PM EST
- Enjoy this article? Help vote it up the 'Vine.
- Public Discussion (1)
Let's hope the treatment works over the long haul and it can be rapidly moved into the mainstream. An amazing story.
You're in Easy Mode. If you prefer, you can use XHTML Mode instead. |
As a new user, you may notice a few temporary content restrictions. Click here for more info.



